An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 5, 2005, Pages 754-756

  Aukst Margetić, Branka ^a   Margetić, Branimir ^a  

^a Neuropsihijatrijska bolnica   (Croatia)

Author keywords

Erectile dysfunction; Loratadine; SSRI

Indexed keywords

ALPRAZOLAM; CLONAZEPAM; DIAZEPAM; FLUOXETINE; FLUVOXAMINE; LORATADINE; NITRAZEPAM; PAROXETINE; PROMAZINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ERECTILE DYSFUNCTION; FUNCTIONAL ASSESSMENT; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; PENIS ERECTION; SCORING SYSTEM; SEXUAL DYSFUNCTION; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT OUTCOME;

ADULT; DEPRESSIVE DISORDER, MAJOR; HISTAMINE H1 ANTAGONISTS; HUMANS; IMPOTENCE; LORATADINE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS;

EID: 21244434919     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.04.007     Document Type: Article

References (12)

1. American Psychiatric Association Diagnostic Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Press Washington, DC
2. J. Angulo, C. Peiro, C.F. Sanchez-Ferrer, S. Gabancho, P. Cuevas, S. Gupta, and I. Saenz de Tejada Differential effects of serotonin reuptake inhibitors on erectile responses, NO production and neuronal NO synthetase expression in rat corpus cavernosum tissue Br. J. Pharmacol. 134 2001 1190 1194
3. R.V. Brubaker Fluoxetine-induced sexual dysfunction reversed by loratadine J. Clin. Psychiatry 63 2002 534
4. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
5. Y.C. Kim, M.G. Davies, T.H. Lee, P.O. Hagen, and C.C. Carson III Characterization and function of histamine receptors in corpus cavernosum J. Urol. 153 1995 506 510
6. L.A. Labbate, H.A. Croft, and M.A. Oleshansky Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation J. Clin. Psychiatry 64 Suppl. 10 2003 11 19
7. S.B. Lare, and L.A. Labbate Sildenafil and erectile dysfunction Am. J. Psychiatry 157 2000 2055 2056
8. H.G. Nurnberg, P.L. Hensley, A.J. Gelenberg, M. Fava, J. Lanziello, and S. Paine Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomised controlled trial JAMA 289 2003 56 64
9. R.C. Rosen, and H. Marin Prevalence of antidepressant-associated erectile dysfunction J. Clin. Psychiatry 64 Suppl. 10 2003 5 10
10. R.C. Rosen, J.C. Cappelleri, M.D. Smith, J. Lipsky, and B.M. Pena Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction Int. J. Impot. Res. 11 1999 319 326
11. A.J. Rotschild Sexual side effects of antidepressants J. Clin. Psychiatry 61 Suppl. 11 2000 28 36
12. M. Yamanaka, M. Kitamura, A. Iwasa, M. Koga, K. Matsumiya, and A. Okuyama Prolonged nocturnal penile tumescence caused by epinastine Int. J. Urol. 6 1999 162 163